Marco Dugo

ORCID: 0000-0002-7822-4587
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • Autoimmune Bullous Skin Diseases
  • Adipokines, Inflammation, and Metabolic Diseases
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Diabetes, Cardiovascular Risks, and Lipoproteins
  • Venous Thromboembolism Diagnosis and Management
  • Vascular Malformations and Hemangiomas
  • Lipoproteins and Cardiovascular Health
  • COVID-19 and healthcare impacts

Arcispedale Sant'Anna
2021

University of Ferrara
2017

Several studies reported a high incidence of pulmonary embolism (PE) among patients with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, but detailed data about clinical characteristics, risk factors these and prognostic role PE are still lacking. We aim to evaluate the occurrence SARS-CoV-2 describe their factors, in-hospital outcomes.This is multicenter Italian study including 333 consecutive admitted seven hospitals from February 22 May 15, 2020. All underwent...

10.1371/journal.pone.0245565 article EN cc-by PLoS ONE 2021-01-22

Background While the relationship between total cholesterol (TC) and cardiovascular disease (CVD) progressively weakens with aging, several studies have shown that low TC is associated increased mortality in older individuals. However, possible additive/synergic contribution of two most important rich fractions (LDL-C HDL-C) to risk has not been previously investigated. Our study aimed investigate baseline LDL-C HDL-C, both separately combined, 9-years a sample community dwelling individuals...

10.1371/journal.pone.0185307 article EN public-domain PLoS ONE 2017-09-28
Coming Soon ...